Table 2.
Association of HE grade with 28-day outcome and 90-day outcome of AoCLD patients.
| Outcome | NO HE (N = 3,610) | HE1 (N = 127) | HE2 (N = 137) | HE3 (N = 55) | HE4 (N = 20) |
|---|---|---|---|---|---|
| 28-day adverse outcome | 351 (9.7) | 23 (18.1) | 35 (25.5) | 26 (47.3) | 13 (65.0) |
| 28-day LT | 147 (4.1) | 5 (3.9) | 4 (2.9) | 7 (12.7) | 2 (10.0) |
| 28-day die | 204 (5.7) | 18 (14.2) | 31 (22.6) | 19 (34.5) | 11 (55.0) |
| 90-day adverse outcome | 594 (16.5) | 36 (28.3) | 52 (38.0) | 32 (58.2) | 14 (70.0) |
| 90-day LT | 204 (5.7) | 7 (5.5) | 6 (4.4) | 7 (12.7) | 2 (10.0) |
| 90-day die | 390 (10.8) | 29 (22.8) | 46 (33.6) | 25 (45.5) | 12 (60.0) |